Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
150
-
Total 13F shares, excl. options
-
33,763,352
-
Shares change
-
+1,224,299
-
Total reported value, excl. options
-
$1,277,904,525
-
Value change
-
+$46,542,763
-
Put/Call ratio
-
46%
-
Number of buys
-
72
-
Number of sells
-
77
-
Price
-
$37.85
Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q4 2016
As of 31 Dec 2016 AERIE PHARMACEUTICALS INC - COM (AERI) had 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 33,763,352 shares of stock of the company.
Largest 10 holders included JENNISON ASSOCIATES LLC, WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C., DEERFIELD MANAGEMENT CO, BlackRock Fund Advisors, Foresite Capital Management III, LLC, Foresite Capital Management II, LLC, ORBIMED ADVISORS LLC, Partner Fund Management, L.P., and VANGUARD GROUP INC.
This table shows 150 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.